Blastic plasmacytoid dendritic cell neoplasm: a comprehensive review in pediatrics, adolescents, and young adults (AYA) and an update of novel therapies
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy that
can involve the bone marrow, peripheral blood, skin, lymph nodes, and the central nervous …
can involve the bone marrow, peripheral blood, skin, lymph nodes, and the central nervous …
Blastic Plasmacytoid Dendritic Cell Neoplasm: A Comprehensive Review of the Disease, Central Nervous System Presentations, and Treatment Strategies
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare, aggressive hematologic
malignancy with poor outcomes. The World Health Organization (WHO) redefined BDCN as …
malignancy with poor outcomes. The World Health Organization (WHO) redefined BDCN as …
North American Blastic Plasmacytoid Dendritic Cell Neoplasm Consortium: position on standards of care and areas of need
N Pemmaraju, H Kantarjian, K Sweet, E Wang… - Blood, 2023 - ashpublications.org
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy
with historically poor outcomes and no worldwide consensus treatment approach. Unique …
with historically poor outcomes and no worldwide consensus treatment approach. Unique …
Tagraxofusp for blastic plasmacytoid dendritic cell neoplasm
MR Luskin, AA Lane - Haematologica, 2023 - pmc.ncbi.nlm.nih.gov
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy that
presents with characteristic dark purple skin papules, plaques, and tumors, but may also …
presents with characteristic dark purple skin papules, plaques, and tumors, but may also …
[PDF][PDF] Blastic plasmacytoid dendritic cell neoplasm: Emerging developments and special considerations for 2023
N Pemmaraju, H Kantarjian - Clin. Adv. Hematol …, 2023 - hematologyandoncology.net
Background Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a highly clinically
aggressive, ultra-rare hematologic malignancy. 1 The worldwide incidence is largely …
aggressive, ultra-rare hematologic malignancy. 1 The worldwide incidence is largely …
Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm
J He, MB Garcia, JS Connors, CA Nuñez… - Journal of Pediatric …, 2023 - journals.lww.com
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy,
especially in pediatrics, that can involve the bone marrow, skin, lymph nodes, and central …
especially in pediatrics, that can involve the bone marrow, skin, lymph nodes, and central …
A systematic literature review of 74 Chinese blastic plasmacytoid dendritic cell neoplasm patients
C Gong, Y Liu, M Zhang - Therapeutic Advances in …, 2024 - journals.sagepub.com
Background: Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive
hematological cancer. Due to its low incidence, researchers struggle to gather sufficient …
hematological cancer. Due to its low incidence, researchers struggle to gather sufficient …
BPDCN: state of the art
N Pemmaraju - Hematology, 2024 - ashpublications.org
The emergence of blastic plasmacytoid dendritic cell neoplasm (BPDCN) as its own distinct
entity within the pantheon of hematologic malignancies is due to the growing understanding …
entity within the pantheon of hematologic malignancies is due to the growing understanding …
How I treat blastic plasmacytoid dendritic cell neoplasm
MA Kharfan-Dabaja, AA Lane, N Pemmaraju - Blood Journal, 2024 - ashpublications.org
Historically, treatment options for blastic plasmacytoid dendritic cell neoplasm (BPDCN)
were limited to conventional chemotherapy, adopted from regimens used to treat acute …
were limited to conventional chemotherapy, adopted from regimens used to treat acute …